MMX mesalamine induces remission of mild-to-moderate ulcerative colitis in patients who have changed directly from other oral 5-ASA therapies and in those who have not previously received or who have discontinued 5-ASA: A combined analysis of two phase III studies [PDF]
, 2007 G Lichtenstein +9 more
openalex +1 more source
Mesalamine prevents dysplasia in patients with inflammatory bowel disease [PDF]
, 2007 Ilan Aharoni +4 more
openalex +1 more source
Induction of oxidative DNA damage by mesalamine in the presence of copper: A potential mechanism for mesalamine anticancer activity [PDF]
, 2011 Mesalamine is the first line pharmacologic intervention for patients with ulcerative colitis, and recent epidemiologic studies have demonstrated a protective association between therapeutic use of the drug and colorectal carcinoma. However, the mechanism
Jia, Zhenquan +1 more
core
A novel, hydrogen sulfide-releasing mesalamine derivative (ATB-429) exhibits enhanced anti-inflammatory and analgesic activity in experimental colitis [PDF]
, 2007 Jennifer Wallace +3 more
openalex +1 more source
Mesalamine-induced myocarditis following diagnosis of Crohn's disease: A case report
Revista Portuguesa de Cardiologia, 2013 Mesalamine is a common treatment for Crohn's disease, and can be rarely associated with myocarditis through a mechanism of drug hypersensitivity. We present the case of a 19-year-old male who developed chest pain two weeks after beginning mesalamine ...
Carlos Galvão Braga +7 more
doaj
How important is mesalamine in the maintenance of steroid-refractory colitis? [PDF]
, 2008 Giovanni C. Actis +3 more
openalex +1 more source
Mesalamine-induced pleuritis in a patient with ulcerative colitis [PDF]
, 2008 Alessandro Tozzi +5 more
openalex +1 more source
Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease [PDF]
, 2007 Avellini, Claudio +3 more
core +1 more source